RaD Fund Act of 2018
Official title: To establish a Rare Disease Therapeutics Corporation to encourage the development of high-risk, high-return therapies for rare diseases, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Rare Disease Fund Act of 2018 or the RaD Fund Act of 2018
This bill requires the Department of the Treasury to organize the Rare Disease Therapeutics Corporation to purchase rights to, fund the development of, and sell ownership interests in drugs, biological products, and medical devices for rare diseases.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6801: RaD Fund Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-6801/
"H.R. 6801: RaD Fund Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-6801/.
H.R. 6801, 115th Cong. (2026), https://openamerica.io/bill/115-HR-6801/.
[H.R. 6801: RaD Fund Act of 2018](https://openamerica.io/bill/115-HR-6801/)